Vol. 7, Issue 2, Part B (2025)

The integration of Artificial Intelligence (AI) into psychiatry represents one of the most transformative shifts in mental health care in the past decade. Psychiatry, historically reliant on subjective clinical judgment and patient self-report, has begun to incorporate data-driven methodologies that enhance diagnostic precision, personalize treatment, and extend access to underserved populations. Machine learning algorithms, natural language processing, and digital phenotyping tools are increasingly being applied to psychiatric practice, providing insights into complex mental health conditions such as depression, schizophrenia, bipolar disorder, and anxiety disorders. AI applications in psychiatry include diagnostic support systems, personalized treatment planning, early detection of relapse, suicide risk prediction, and novel therapeutic interventions delivered via digital platforms. Importantly, wearable technologies and smartphone-based data collection have enabled the capture of real-time behavioral and physiological markers, improving monitoring and intervention strategies. Despite these advances, challenges remain regarding data privacy, ethical considerations, algorithmic bias, regulatory frameworks, and integration with traditional clinical practice. Moreover, the “black-box” nature of deep learning models poses significant barriers to transparency and clinician acceptance. This review synthesizes the current landscape of AI applications in psychiatry, with a focus on diagnostic enhancement, treatment personalization, digital phenotyping, predictive analytics, and ethical considerations. The paper highlights both the transformative potential and the limitations of AI, emphasizing the need for interdisciplinary collaboration to ensure safe, equitable, and effective deployment in psychiatric care. The review concludes with future directions for research and clinical implementation, underscoring AI’s promise to augment not replace human expertise in psychiatry.